Rhythm Pharmaceuticals Receives Positive Recommendation from NICE for IMCIVREE for Treatment of Obesity and Hyperphagia in Patients with Bardet-Biedl Syndrome

BOSTON - Rhythm Pharmaceuticals, Inc. , a global commercial-stage biopharmaceutical company focused on transforming the lives of patients and their families living with rare neuroendocrine diseases,...

Related Keywords

United Kingdom ,Northern Ireland ,Craigavon ,Boston ,Massachusetts ,United States ,Philip Beales ,David Connolly ,Yann Mazabraud ,Adam Daley ,National Institute For Health ,Scottish Medicines Consortium ,Healthcare Products Regulatory Agency ,Head Of International ,Nasdaq ,Institute Of Child Health ,Drug Administration ,Medicines Healthcare Products Regulatory Agency ,Rhythm Pharmaceuticals Inc ,Exchange Commission ,European Commission ,Rhythm Pharmaceuticals ,National Health Service ,European Union ,Care Excellence ,Executive Vice President ,Ormond Street Institute ,European Marketing Authorization ,Highly Specialised Technologies ,Medicines Consortium ,Pre Existing Nevi ,Sexual Arousal ,Suicidal Ideation ,Serious Adverse Reactions Due ,Benzyl Alcohol Preservative ,Low Birth Weight Infants ,Private Securities Litigation Reform Act ,Risk Factor ,Quarterly Report ,News Publishing ,